ORBITA Study: 60 Second Insights
Published: 03 August 2018
-
Views:
1542
-
Likes:
7
-
Views:
1542
-
Likes:
7
-
Up Next -
33sPart 5 | Session 3 Darrel Francis
-
1m 9sPart 5 | Session 4 Rasha Al-Lamee
-
13sPart 6 | Session 1 Gregg Stone
-
39sPart 6 | Session 2 Ajay Kirtane
-
56sPart 6 | Session 3 Darrel Francis
-
1m 11sPart 6 | Session 4 Rasha Al-Lamee
-
1m 11sPart 7 | Session 1 Gregg Stone
-
34sPart 7 | Session 2 Ajay Kirtane
-
1m 6sPart 7 | Session 3 Darrel Francis
-
1m 4sPart 7 | Session 4 Rasha Al-Lamee
-
28sPart 1 | Session 1 Gregg Stone Gregg Stone
-
49sPart 1 | Session 2 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 1 | Session 3 Darrel Francis Darrel P Francis
-
37sPart 1 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
1m 1sPart 2 | Session 1 Gregg Stone Gregg Stone
-
46sPart 2 | Session 2 Ajay Kirtane Ajay J Kirtane
-
1m 8sPart 2 | Session 3 Darrel Francis Darrel P Francis
-
1m 9sPart 2 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
31sPart 3 | Session 1 Gregg Stone Gregg Stone
-
43sPart 3 | Session 2 Ajay Kirtane Ajay J Kirtane
-
1m 6sPart 3 | Session 3 Darrel Francis Darrel P Francis
-
1m 16sPart 3 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
39sPart 4 | Session 1 Gregg Stone Gregg Stone
-
31sPart 4 | Session 2 Ajay Kirtane Ajay J Kirtane
-
52sPart 4 | Session 3 Darrel Francis Darrel P Francis
-
1m 12sPart 4 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
21sPart 5 | Session 1 Gregg Stone Gregg Stone
Overview
A short series of 60-second insight videos on the ORBITA Study. Hear the expert views in under one minute!
More from this programme
Part 1
Can you describe the ORBITA study in your own words?
Part 2
Why do you think that ORBITA failed to show a significant improvement in exercise capacity post PCI?
Part 3
After the results of ORBITA should we stop stenting?
Part 4
What was the biggest weakness of ORBITA?
Part 5
What is the biggest strength of ORBITA?
Part 6
How has ORBITA affected your clinical practice?
Part 7
Is there a need for further studies?
Faculty Biographies
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…